These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 606765)

  • 21. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
    Johansson BE; Moran TM; Bona CA; Kilbourne ED
    J Immunol; 1987 Sep; 139(6):2015-9. PubMed ID: 2957444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
    Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related heterologous antibody responses to influenza virus vaccination.
    Noble GR; Kaye HS; Kendal AP; Dowdle WR
    J Infect Dis; 1977 Dec; 136 Suppl():S686-92. PubMed ID: 606792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
    Kilbourne ED; Couch RB; Kasel JA; Keitel WA; Cate TR; Quarles JH; Grajower B; Pokorny BA; Johansson BE
    Vaccine; 1995 Dec; 13(18):1799-803. PubMed ID: 8701596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ether-treated, subunit Hsw1N1 influenza vaccines: response of immunologically primed subjects to two antigenic variants.
    Brandon FB; Shillis JL; Beardmore WB; Smith TC; Brackett RG
    J Infect Dis; 1977 Dec; 136 Suppl():S539-45. PubMed ID: 606773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses of elderly and chronically ill subjects to bivalent influenza A/New Jersey/8/76 (Hsw1N1)-A/Victoria/3/75 (H3N2) vaccines.
    Douglas RG; Bentley DW; Brandriss MW
    J Infect Dis; 1977 Dec; 136 Suppl():S526-32. PubMed ID: 342625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-neuraminidase antibody response after administration of a split influenza vaccine.
    Constantinescu C; Ioniţă E; Alexandrescu V; Maţepiuc M; Creţescu L; Niculescu IT
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):37-41. PubMed ID: 4038049
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles children.
    Boyer KM; Cherry JD; Welliver RC; Deseda-Tous J; Zahradnik JM; Dudley JP; Krause PJ; Bryson YJ; Spencer MJ
    J Infect Dis; 1977 Dec; 136 Suppl():S661-4. PubMed ID: 342631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children.
    Allison JE; Glezen WP; Taber LH; Paredes A; Webster RG
    J Infect Dis; 1977 Dec; 136 Suppl():S672-6. PubMed ID: 606790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on anti-neuraminidase antibody response in serum after inoculation of influenza hemagglutinin vaccines].
    Hiromatsu Y; Sato Y; Inoguchi T; Umeno H; Kurosawa Y; Ishii K; Kobayashi K; Kaji M; Shingu T; Hayashida K
    Kansenshogaku Zasshi; 1984 May; 58(5):367-75. PubMed ID: 6434660
    [No Abstract]   [Full Text] [Related]  

  • 34. Single-dose trials of monovalent A/New Jersey/76 (Hsw1N1) influenza virus vaccine in children in Durham, North Carolina.
    Gutman LT; Wilfert CM; Idriss ZH; Schmidt E; Andrews S; Katz SL
    J Infect Dis; 1977 Dec; 136 Suppl():S575-8. PubMed ID: 606774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses.
    Ennis FA; Wise TG; McLaren C; Verbonitz MW
    Dev Biol Stand; 1977 Jun 1-3; 39():261-6. PubMed ID: 604108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E; Werner J; Franke G; Paulus W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
    Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
    Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influenza vaccination in dialysis patients].
    Haldimann B; Descoeudres C
    Schweiz Med Wochenschr; 1978 Jan; 108(2):52-5. PubMed ID: 622534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
    Petrie JG; Ohmit SE; Johnson E; Truscon R; Monto AS
    J Infect Dis; 2015 Dec; 212(12):1914-22. PubMed ID: 26014800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.